lobbying_activities: 2838453

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2838453	178f6e09-20fd-4096-8fa0-f6bf64e0da62	Q2	BUCHANAN INGERSOLL & ROONEY PC	55291	GENERIC ANIMAL DRUG ALLIANCE	2022	second_quarter	ANI	Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2022-07-20T11:09:43-04:00